Heart failure with mid-range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines.

Classification Heart failure with mid-range ejection fraction Heart failure with preserved ejection fraction Heart failure with reduced ejection fraction

Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
04 2020
Historique:
received: 12 08 2019
revised: 09 11 2019
accepted: 12 11 2019
pubmed: 3 4 2020
medline: 22 6 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid-range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of these patients. So far, the analysis of trials, registries, and observational studies have demonstrated that patients with mid-range LVEF belong to a patient cohort with generally intermediate clinical profile as compared with other groups but with a remarkable variety of intrinsic phenotypes. This is due to the limitations of LVEF as the sole criterion to categorize patients with HF and characterize their prognosis, above all when it is >40%. To better define the HFmrEF phenotype, it is reasonable to consider other parameters, such as LVEF changes over time, HF aetiology, co-morbidities, and other imaging parameters. A multiparametric evaluation may contextualize a patient with HFmrEF in a more defined phenotype with a specific prognosis.

Identifiants

pubmed: 32239646
doi: 10.1002/ehf2.12586
pmc: PMC7160484
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-399

Subventions

Organisme : American Heart Association
ID : 17MCPRP33460225
Pays : International

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

N Engl J Med. 2014 Apr 10;370(15):1383-92
pubmed: 24716680
Eur Heart J. 2016 Feb 1;37(5):455-62
pubmed: 26374849
Eur J Heart Fail. 2019 Oct;21(10):1169-1186
pubmed: 31129923
Circulation. 2015 Jan 20;131(3):269-79
pubmed: 25398313
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Circ Heart Fail. 2016 Nov;9(11):
pubmed: 28029640
Eur J Heart Fail. 2017 Dec;19(12):1606-1614
pubmed: 28371075
Circulation. 2005 Dec 13;112(24):3738-44
pubmed: 16330684
Eur J Heart Fail. 2018 Mar;20(3):427-430
pubmed: 29314500
Eur J Heart Fail. 2017 Apr;19(4):552-562
pubmed: 27748006
Eur J Heart Fail. 2017 Dec;19(12):1597-1605
pubmed: 29024350
Am J Cardiol. 2009 Mar 15;103(6):845-51
pubmed: 19268743
Eur J Heart Fail. 2017 Dec;19(12):1615-1623
pubmed: 28387002
Diab Vasc Dis Res. 2018 Nov;15(6):494-503
pubmed: 30176743
Eur Heart J. 2016 Jun 1;37(21):1642-50
pubmed: 26417058
Eur J Heart Fail. 2018 Mar;20(3):560-568
pubmed: 29164753
N Engl J Med. 2019 Jan 24;380(4):347-357
pubmed: 30415602
Eur J Heart Fail. 2014 Oct;16(10):1049-55
pubmed: 25210008
JACC Heart Fail. 2014 Apr;2(2):97-112
pubmed: 24720916
Eur J Heart Fail. 2017 Jul;19(7):893-900
pubmed: 28194841
J Am Coll Cardiol. 2010 Nov 23;56(22):1812-22
pubmed: 21087709
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1215-1226
pubmed: 30031704
Eur J Heart Fail. 2017 Oct;19(10):1258-1269
pubmed: 28370829
Eur J Heart Fail. 2018 Aug;20(8):1230-1239
pubmed: 29431256
ESC Heart Fail. 2020 Apr;7(2):381-399
pubmed: 32239646
Eur Heart J. 2012 Jul;33(14):1750-7
pubmed: 21821849
Circ Heart Fail. 2017 Jun;10(6):
pubmed: 28615366
J Am Heart Assoc. 2015 Dec 23;4(12):
pubmed: 26702084
Eur J Heart Fail. 2018 Jul;20(7):1139-1145
pubmed: 29493058
J Card Fail. 2016 Sep;22(9):726-30
pubmed: 27475878
JACC Heart Fail. 2017 Nov;5(11):763-771
pubmed: 29032140
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):260-274
pubmed: 29413646
JACC Heart Fail. 2019 Apr;7(4):306-317
pubmed: 30852236
N Engl J Med. 2019 Oct 24;381(17):1609-1620
pubmed: 31475794
JACC Heart Fail. 2019 Jun;7(6):447-456
pubmed: 31146871
Eur Heart J. 2018 Jan 1;39(1):26-35
pubmed: 29040525
J Am Coll Cardiol. 2017 Oct 17;70(16):1949-1961
pubmed: 28855115
Am J Cardiol. 2014 Sep 15;114(6):862-8
pubmed: 25092194
Eur Heart J. 2017 Apr 14;38(15):1119-1127
pubmed: 28369340
Am Heart J. 2014 Nov;168(5):721-30
pubmed: 25440801
Circ Cardiovasc Imaging. 2009 Sep;2(5):356-64
pubmed: 19808623
J Am Coll Cardiol. 2007 Aug 21;50(8):768-77
pubmed: 17707182
Eur J Heart Fail. 2017 Dec;19(12):1586-1596
pubmed: 28295985
J Am Coll Cardiol. 2018 May 8;71(18):1947-1957
pubmed: 29724346
Am J Cardiol. 2008 Apr 15;101(8):1151-6
pubmed: 18394450
Eur J Prev Cardiol. 2016 Jan;23(1):78-85
pubmed: 25520380
Circ Heart Fail. 2016 Apr;9(4):e002826
pubmed: 27009553
JACC Heart Fail. 2016 Jun;4(6):464-72
pubmed: 27256749
J Am Coll Cardiol. 2012 Dec 18;60(24):2465-72
pubmed: 23158527
Eur J Heart Fail. 2018 Dec;20(12):1615-1633
pubmed: 30411833
J Nucl Cardiol. 2019 May 29;:
pubmed: 31144228
Heart Lung Circ. 2018 Oct;27(10):1123-1208
pubmed: 30077227
Eur J Heart Fail. 2017 Dec;19(12):1574-1585
pubmed: 28386917
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
J Am Coll Cardiol. 2015 Oct 13;66(15):1714-28
pubmed: 26449143
Eur J Heart Fail. 2018 Sep;20(9):1257-1266
pubmed: 29917301
Lancet. 2003 Sep 6;362(9386):777-81
pubmed: 13678871
Eur Heart J. 2019 Jul 1;40(26):2155-2163
pubmed: 30957868
Eur J Heart Fail. 2018 Mar;20(3):431-432
pubmed: 29333631
Eur J Heart Fail. 2018 Nov;20(11):1559-1566
pubmed: 30070041
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358
J Card Fail. 2018 Jun;24(6):365-374
pubmed: 29597053
Medicine (Baltimore). 2019 Mar;98(13):e14967
pubmed: 30921200
Eur J Heart Fail. 2014 Mar;16(3):334-41
pubmed: 24464687
Eur J Heart Fail. 2017 Dec;19(12):1569-1573
pubmed: 29067761
Eur J Heart Fail. 2017 Dec;19(12):1638-1647
pubmed: 28849609
JACC Heart Fail. 2017 Aug;5(8):565-574
pubmed: 28711451
J Am Coll Cardiol. 2019 Sep 17;74(11):1491-1493
pubmed: 31514952
Eur J Heart Fail. 2017 Dec;19(12):1624-1634
pubmed: 28948683
JACC Heart Fail. 2017 Jul;5(7):507-517
pubmed: 28624483
N Engl J Med. 2000 Apr 13;342(15):1077-84
pubmed: 10760308
J Am Coll Cardiol. 2018 Nov 6;72(19):2360-2379
pubmed: 30384893

Auteurs

Luca Branca (L)

Cardiothoracic Department, Civil Hospitals; Department of Medical and Surgical Specialities, Radioloogical Sciences, Public Health, University of Brescia, Brescia, Italy.

Marco Sbolli (M)

Cardiothoracic Department, Civil Hospitals; Department of Medical and Surgical Specialities, Radioloogical Sciences, Public Health, University of Brescia, Brescia, Italy.

Marco Metra (M)

Cardiothoracic Department, Civil Hospitals; Department of Medical and Surgical Specialities, Radioloogical Sciences, Public Health, University of Brescia, Brescia, Italy.

Marat Fudim (M)

Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Duke Clinical Research Institute, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH